SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.

[1]  B. Frey,et al.  The human splicing code reveals new insights into the genetic determinants of disease , 2015, Science.

[2]  C. Oubridge,et al.  Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5′ splice site recognition , 2015, eLife.

[3]  Anirvan Ghosh,et al.  SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy , 2014, Science.

[4]  Y. Hua,et al.  Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[5]  John A. Tallarico,et al.  SEC-TID , 2014, Journal of biomolecular screening.

[6]  T. Akay,et al.  Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation. , 2014, The Journal of clinical investigation.

[7]  A. Gregory Matera,et al.  A day in the life of the spliceosome , 2014, Nature Reviews Molecular Cell Biology.

[8]  M. Lewandowska.  The missing puzzle piece: splicing mutations. , 2013, International journal of clinical and experimental pathology.

[9]  E. Lara-Pezzi,et al.  The Alternative Heart: Impact of Alternative Splicing in Heart Disease , 2013, Journal of Cardiovascular Translational Research.

[10]  A. Krainer,et al.  Pick one, but be quick: 5' splice sites and the problems of too many choices. , 2013, Genes & development.

[11]  Wendy M. Knowlton,et al.  Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models. , 2012, Human molecular genetics.

[12]  Ruben Abagyan,et al.  ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader , 2012, J. Chem. Inf. Model..

[13]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[14]  Xuexiu Zheng,et al.  Targeting RNA-splicing for SMA treatment , 2012, Molecules and cells.

[15]  Jie Zhang,et al.  SpliceDisease database: linking RNA splicing and disease , 2011, Nucleic Acids Res..

[16]  M. Rich,et al.  Temporal requirement for high SMN expression in SMA mice. , 2011, Human molecular genetics.

[17]  J. Kissel,et al.  Spinal muscular atrophy: a timely review. , 2011, Archives of neurology.

[18]  N. Nagan,et al.  Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens , 2011, European Journal of Human Genetics.

[19]  Marcel H. Schulz,et al.  Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments , 2010, Nucleic acids research.

[20]  A. Brivanlou,et al.  An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. , 2009, Cell stem cell.

[21]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[22]  Yael Mandel-Gutfreund,et al.  A computational approach for genome-wide mapping of splicing factor binding sites , 2009, Genome Biology.

[23]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[24]  K. Fischbeck,et al.  Regulation of SMN Protein Stability , 2008, Molecular and Cellular Biology.

[25]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[26]  M. Winberg,et al.  Identification of a battery of tests for drug candidate evaluation in the SMNΔ7 neonate model of spinal muscular atrophy , 2008, Experimental Neurology.

[27]  Mitchell R Lunn,et al.  Spinal muscular atrophy , 2008, The Lancet.

[28]  C. Burge,et al.  Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. , 2008, RNA.

[29]  Y. Hua,et al.  Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. , 2008, American journal of human genetics.

[30]  Elisa Goina,et al.  Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant , 2008, Molecular and Cellular Biology.

[31]  F. Major,et al.  The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data , 2008, Nature.

[32]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[33]  C. Sumner,et al.  Molecular Mechanisms of Spinal Muscular Atrophy , 2007, Journal of child neurology.

[34]  T. Owa,et al.  Splicing factor SF3b as a target of the antitumor natural product pladienolide , 2007, Nature Chemical Biology.

[35]  Brenda F Baker,et al.  Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon , 2007, PLoS biology.

[36]  E. Androphy,et al.  Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes , 2006, Nucleic acids research.

[37]  U. Monani.  Spinal Muscular Atrophy: A Deficiency in a Ubiquitous Protein; a Motor Neuron-Specific Disease , 2005, Neuron.

[38]  Tatiana Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[39]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[40]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[41]  C. Lorson,et al.  An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA , 2001, Gene Therapy.

[42]  H Roos,et al.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. , 2000, Journal of medicinal chemistry.

[43]  G. Neri,et al.  Detection of the survival motor neuron (SMN) genes by FISH: further evidence for a role for SMN2 in the modulation of disease severity in SMA patients. , 1999, Human molecular genetics.

[44]  J. McPherson,et al.  A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. , 1999, Human molecular genetics.

[45]  C. Lorson,et al.  A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Gilliam,et al.  Differential SMN2 expression associated with SMA severity , 1998, Nature Genetics.

[47]  J. Mendell,et al.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. , 1997, American journal of human genetics.

[48]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[49]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[50]  A. Krainer.  Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs. , 1988, Nucleic acids research.

[51]  Michael R. Green,et al.  Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro , 1984, Cell.

[52]  U. Monani,et al.  SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. , 2005, Human molecular genetics.

[53]  B. Kastner,et al.  Purification of U small nuclear ribonucleoprotein particles. , 1999, Methods in molecular biology.